| Accession | HRS899340 |
|---|---|
| BioSample Accession | SAMC2930715 |
| Individual accession | HRI684563 |
| Study accession | HRA005098 |
| Sample name | P2_2_BLDC |
| Sample title | P2_2_BLDC |
| Collection date | 2021-03-26 |
| Sample Type | Disease |
| Description | Tislelizumab plus cetuximab and irinotecan in patients with previously treated MSS and RAS wild-type advanced colorectal cancer |
| Tissue | blood cell |
| Release date | 2024-06-01 |